Pharma

Your Article Summary

See Latest Articles

AVI BioPharma Appoints Drs. Christopher S. Henney and M. Kathleen Behrens to Its Board of Directors
AVI BioPharma, 04/01/09

AVI BioPharma, Inc. , a developer of RNA-based drugs, announced the appointment of Christopher S. Henney, Ph.D., D. Sc. and M. Kathleen Behrens, Ph.D. to the Company's Board of Directors effective today. The Company also announced that Company Director John Fara, Ph.D. has decided that he will not stand for re-election to the Board at the Company's upcoming annual meeting.

Today in Execs on the Move...keeping you current

Receive free subspecialty "5-minute updates" via email

ImmunoGen, Inc. Appoints Suzanne Cadden as Vice President, Regulatory Affairs & Quality
ImmunoGen, Inc., 12/18/09

Boston Scientific Announces Election of Nelda Connors to Its Board of Directors
Boston Scientific, 12/17/09

Sanofi-aventis Board of Directors of December 2009
Sanofi-aventis, 12/17/09

 See all of Execs on the Move